Login to Your Account

U.S. Patent disclosures

Tuesday, May 27, 2014
Alzheon Inc., of Lexington, Mass., received a notice of allowance for U.S. Patent application No. 11/871,639, "Methods, Compounds, Compositions and Vehicles for Delivering 3-Amino-1-Propanesulfonic Acid," for its lead therapeutic candidate ALZ-801. ALZ-801 is in a pivotal phase II/III study in Alzheimer's disease patients positive for ε4 allele of the apolipoprotein E.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription